0001493152-17-013894.txt : 20171128
0001493152-17-013894.hdr.sgml : 20171128
20171128172812
ACCESSION NUMBER: 0001493152-17-013894
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20171128
DATE AS OF CHANGE: 20171128
EFFECTIVENESS DATE: 20171128
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ONCOSEC MEDICAL Inc
CENTRAL INDEX KEY: 0001444307
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980573252
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0731
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-299625
FILM NUMBER: 171226254
BUSINESS ADDRESS:
STREET 1: 5820 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 210-7333
MAIL ADDRESS:
STREET 1: 5820 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: NetVentory Solutions, Inc.
DATE OF NAME CHANGE: 20080902
D
1
primary_doc.xml
X0708
D
LIVE
0001444307
ONCOSEC MEDICAL Inc
5820 NANCY RIDGE DRIVE
SAN DIEGO
CA
CALIFORNIA
92121
855-662-6732
NEVADA
None
NetVentory Solutions, Inc.
Corporation
true
Punit
Dhillon
5820 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Avtar
Dhillon
5820 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Director
James
DeMesa
5820 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Director
Anthony
Maida
5820 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Director
Annalisa
Jenkins
5820 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Director
Daniel
O'Connor
5820 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Richard
Slansky
5820 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2017-11-13
false
true
true
false
0
H.C WAINWRIGHT & CO., LLC
375
None
None
430 PARK AVENUE
4TH FLOOR
NEW YORK
NY
NEW YORK
10022
NJ
NEW JERSEY
NY
NEW YORK
TX
TEXAS
false
5685507
5685507
0
9
false
9
78258
0
The issuer will pay a 5.5% commission fee to H.C. Wainwright upon exercise of certain warrants issued in this offering. The above figure represents the total amount payable upon full exercise of all the warrants to which the commission fee applies.
0
false
ONCOSEC MEDICAL Inc
/s/ Richard B. Slansky
Richard B. Slansky
CHIEF FINANCIAL OFFICER
2017-11-28